The Post Intensive Care Syndrome Follow-up and Management Study: The ICU Recovery Answers Project
ICURA
Implementation of a Digital Tool for the Telematic Follow-up and Management of Emotional and Cognitive Sequelae Related to Post-intensive Care Syndrome: Impact on Quality of Life and Functionality
1 other identifier
interventional
360
1 country
1
Brief Summary
Critically ill survivors develop mental health, cognition, and mobility sequelae known as Post-Intensive Care Syndrome (PICS). Clinically significant symptoms of post-traumatic stress, depression, anxiety, and cognitive impairment are frequently observed at short- and long-term after ICU, impacting quality of life of the survivors and their relatives. The main objective of the project is to optimize, implement and evaluate the impact in quality of life of a digital platform (ICURA) specifically designed for following-up and managing the mental health sequelae related to PICS in ICU survivors and their relatives during the one-year recovery phase. Methods: Observational, prospective and multicenter study including two cohorts: 1) ICU patients' cohort (ICUcohort), and 2) ICU patients' family cohort (ICU-F-cohort). After ICU discharge, patients will be randomized to participate in a follow-up with ICURA vs. the standard follow-up. Expected results: Critically ill survivors in the APPICS program after ICU will show better levels of functionality and quality of life than those participants in the usual follow-up. APPICS will contribute to enhancing the prognosis of emotional alterations during the 12 months after ICU both, in ICU survivors, and relatives. Analyzing risk factors, based on demographic and clinical data, will help to the early detection of long-term mental health difficulties in ICU survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedStudy Start
First participant enrolled
October 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedMarch 12, 2026
March 1, 2026
1.5 years
June 18, 2024
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Health-related quality of life
12-Item Short Form Survey (SF-12) Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.
1, 6, 12 months after ICU discharge
Functionality
WHO Short Disability Assessement Schedule (WHODAS 2.0) Scores range from 0 to 60, with higher scores indicating higher level of disability.
1, 6, 12 months after ICU discharge
Secondary Outcomes (4)
Anxiety symptoms
1,6,12 months after ICU discharge
Depressive symptoms
1, 6, 12 months after ICU discharge
Post-Traumatic Stress symptoms
1, 6, 12 months after ICU discharge
Cognitive status
1, 6, 12 months after ICU discharge
Study Arms (2)
ICURA follow-up
EXPERIMENTALStandard Group
NO INTERVENTIONInterventions
Using a telehealth platform for the detection of the emotional, neuropsychological and physical PICS-related sequelae along 12 months in ICU survivors
Eligibility Criteria
You may qualify if:
- Adult (≥18 years old) critically ill patients admitted to the ICU with or without need of invasive mechanical ventilation (IMV).
You may not qualify if:
- Severe neurological pathology (including dementia or focal brain damage with functional and cognitive impairment) prior to admission to the ICU.
- Severe psychiatric pathology (schizophrenia, bipolar disorder, major depressive disorder)
- Intellectual disability (IQ \<80).
- Patients who develop secondary complications (infections, stroke, TBI or any non-transient acquired brain damage) after ICU discharge, that may compromise the results of the emotional and neuropsychological evaluation during the recovery phase
- Moderate-severe cognitive impairment (Short-IQCODE \>85) that impair ICU patients an independent participation in the telematic follow up and accompaniment program
- Readmission to ICU within 12 months after discharge from ICU
- Idiomatic barrier (non spanish and/or catalan speaker)
- Patients with life expectancy \<1 year or not subsidiaries of active treatment measures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corporacion Parc Taulilead
- Universitat de les Illes Balearscollaborator
- Hospital Son Espasescollaborator
- Fundació La Marató de TV3collaborator
Study Sites (1)
Institut d'Investigació i Innovació Parc Taulí
Sabadell, Barcelona, 08208, Spain
Related Links
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 18, 2024
First Posted
July 17, 2024
Study Start
October 2, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
March 12, 2026
Record last verified: 2026-03